Name of Physician or Study Coor 1nator

Clinical Information

Clinical Findings:

Performance Scale (Karnofsky Score):
El 60-70 Symptomatic, in bed less than 50% of day

a 100 Asymptomatic [a 80-90 Symptomatic but Fully Ambulatory
a 40-50 S m tomatic, in bed more than 50% of da , but not bed ridden E] 20—30 Bed Ridden

URRENTi MEDICATION

 

 

 
 
  

Disease

Status
CI Pre-menopausal
El Peri-Menopausal
Post-menopausal

  
  

PAST'MEDICAL’ HISTO
Disorder

   

Date

Date of First Menses
(

of Last Menses
6

Birth Control: [I Condom [J Oral Contraceptive
D Other:

Current Status
I: YES 0

Current Status
1:: YES 0

Current Status
El YES NO

Relative

Test Result

HIV N D Positive:
H B N El Positive:
H C I] Positive:

AFP D D Positive:

Other:

B/T Cell Markers:

TYPE

[1 Negative El Positive:

Environmental Hazards:
Smoki Histo

  
   
  

 
    

Treatment

 

Therapy:

Packs Duration

Alcohol Consum

Drinks Duration

Use

Duration

EJN
El

UN
CIN

El Negative

Result

El Positive:
D Positive:
CI Positive:
El Positive:

El Positive:

 

 

 

 

    
    
   
  

  

C STUD
Results
Ultrasound

X-Ra

CT
Endosco
MRI
Bio

  
   
 
    
 
 
  
  

  

Clinical
Location of Involved L Nodes Location of Distant Metastasis

Clinical
T N M 0 Stage:

 

Treatment Informationl

 

Procedure

Pri Tumor
Detailed Location

Extension of Tumor

L Nodes
Location of L Nodes Nodes

Palpable, Non—Dissected Lymph Nodes
Dissected Lymph Nodes

Distant Metastasis
Detailed Location

Su ical S
T N M e

  

 

I EOADJUVENT THERAPY (Chemo Radiation Immuno,Homional or Molecular) V ET.

Dose Route Freguengy Date (mm/dd/yyyy)
/ / To /

 

 

____’___._..__-——
/

 

 

______________._.——
/

 

 

/ /
/ /
__________ //To/
/ /

____,__,,___.__———
/

 

 

 

 

 

 

 

 

 

 

 

 

Pathology Form

Parafﬁn Block Blood/Serum/Plasma Slide

Frozen
Diseased Normal Diseased Normal

Diseased Normal Diseased Normal

e to Formalin Time to LN2
‘ min

Time to LN2

Prima Tumor
Size Extension of Tumor Distance to NAT

g“ X X cm cm

L Nodes
Location # Examined # Metastasized

Distant Metastasis
Detailed Location

Patho ical
pT 2,. N M (9 Stage:

{7% MM; Wezﬁﬂe)

a

 

 

     

 

 

Microscopic Descripti

 

Cell Distribution
Diffuse
Mosaic
Necrosis
L Inﬁltration
Vascular Invasion
Clusterized
Alveolar Formation
Indian File

mous + - Adenomatous
Cell Glandular cell
Cell Cell Stratification
Secretion
Vacuole
Gland formation
Cellular Differentiation:

Keratin
Desmosome
Peaﬂ

Nuclear
Aniso Nucleosis

Nucleolar Prominent
Multinucleated Giant Cell
Mitotic

  

Structural Pattern
Streami
Storiform
Fibrosis

Calciﬁcation

Sarcomatous + - L
Round Cell Cell
Fibroblast Small Cell
Osteoblast RS Like
Inﬂam. Cell
Plasma Cell

Well Moderate Poor

II

Nuclear Grade:

Result

El Positive
El Positive
El Positive
:1 Positive
1: Positive
1: Positive
r3 Positive

Marker
ER ve
pR ve

Her- neu '
B-Cell Marker
T-Cell Marker

Other:
Other:

 

 

' al Patholo

Reo

 

I. Histological pattern.-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

. . CELL DISTRIBUTION + - STRUCTURAL PATTERN + -
D'ffuse * x Streaming
M053” ll Storiform
Necrosis k' Fibrosis
Lymphocytic Inﬁltration A! , Palisading
Vascular Invasion ' Cystic Degeneration
Clusterized i3! Bleeding
Alveolar Formation M Myxoid Change
Indian File 3! Psammoma/Calciﬂcation

2. Cellular features:

Squamous + - Adenomatous + - Sarcomatous + - Lymphomatous + -
Squamoid Cell Glandular cell a! Round Cell Cell
Spindle Cell Cell Stratiﬁcation M Fibroblast Small Cell .
Keratin Secretion X Osteoblast RS Cell/RS Like
Desmosome lnlmcyt. Vacuole X . Lipoblast lnﬂam. Cell
Pearl Gland formation Myoblast Plasma Cell

 

 

 

 

 

 

 

 

 

 

 

 

Otherwise Speciﬁed: P] 715% P53] 7a?

 

DZ 7H bfrmy

 

2. Cellular Di eremiation:

 

Well

Poor

 

 

 

Moderately
i5?

 

 

 

3. Nuclear

Nucleosis

Nucleolar Prominent

Mitotic

Nuclear

Giant Cell

Nuclear Grade

istolo ical Dia osis: gray/«C49 WMW

 

ﬁlm (JNMWW La”;

   

